Cargando…
Assessment of the reporting quality of randomized controlled trials related to the pharmacotherapy of COVID-19 based on the CONSORT 2010 checklist: a systematic review
Autores principales: | Jung, Youn-Joo, Oh, Yunkyoung, Purja, Sujata, Jeong, Hyokeun, Kim, EunYoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733238/ https://www.ncbi.nlm.nih.gov/pubmed/34999174 http://dx.doi.org/10.1016/j.cmi.2021.12.016 |
Ejemplares similares
-
Utilization of the CONSORT checklist to enhance clinical trials reporting – A critical analysis
por: Kumar, Annapurna, et al.
Publicado: (2021) -
IJD(®): Consorting with CONSORT 2010
por: Panda, Saumya, et al.
Publicado: (2013) -
CONSORT 2010 statement: extension checklist for reporting within person randomised trials
por: Pandis, Nikolaos, et al.
Publicado: (2017) -
A Systematic Review on Neurological Aspects of COVID-19: Exploring the Relationship Between COVID-19-Related Olfactory Dysfunction and Neuroinvasion
por: Purja, Sujata, et al.
Publicado: (2022) -
Reporting of randomized controlled trials as per CONSORT guidelines
por: Misra, Puneet, et al.
Publicado: (2022)